A REVIEW ON NANOPARTICLES COMBINED ANTIBIOTICS IN SUPPRESSING BACTERIAL RESISTANCE
Keywords:
Antibiotic-resistance mechanisms, Combination therapy, Nanoparticles, SynergismAbstract
Recent World Health Organization reports put much emphasis on the issue of bacterial resistance to antibiotic therapy. Multi-drug resistance (MDR) has prompted researchers for alternative to monotheraputic approach by introducing nanotechnology that involve in their diverse sense – materials (metals / metal oxides), synthesis (organic / phytogenic) and synergistic dynamical interaction. Toxicity in host cells emerged as limitation to this approach. Green nanotechnology with the ease of employment is hoped to be less toxic but need to be researched further with emphasis on in-vivo arena to gain acceptability. This review is intended to shed a light on MDR organisms and elimination strategies and current approaches of nanotechnologies that are utilized in the path to eradicate MDR especially the combinational therapy of synthetic or green NPs with antibiotics
References
O'Neill J. Antimicrobial resistance: tackling a crisis for the health and wealth of nations. Rev. Antimicrob. Resist. 20 (2014), 16
Baptista P.V. , Carvallo M.A. Nano – strategies to fight multidrugResistance bacteria – "a battle of the titans". Front. Microbiol. 9. 1441.Doi.10.3389/fmicb. 2018/01441
Ruddaraju L.K. , Pammi S.V.N. , Guntuku G. et al , A review on anti-bacterials to combat resistance from ancient era of plants and metals to present and future perspectives of green nano technological combinations. Asian J. Pharma. Sci. 15(1) (2020), 42-59
Mostafa A.A. , AlAskar A.A. , Almaary K.S. , Dawoud T.M. , Sholkam E.N.Bakri M.M. Antimicrobial activity of some plant extracts against bacterial strains causing food poisoning diseases. Saudi J. Biol. Sci. 25 (2) (2018), 361-366
Mba I.E. , Nweze E.I. Nanoparticles as thearaputic options for treating multi-drugresistant bacteria: research progress, challenges and prospects. World J. Micribio. & Biotechno. 37(108) (2021), 1-30
Lee N.Y. , Ko W.C. , Hsueh P.R. Nanoparticles in the treatment of infections caused by multidrug resistant organisms. Front. Pharmacol. 10 (2019), Article 1153
Munir M.U. , Ahmed M. , Usman M. , Salman S. Recent advances in nanotechnology aided materials as antibiotics substitutes. Inter. J. Nanomed. 15 (2020), 7329-7358
Gupta D. , Singh A. , Khan A.U. Nanoparticles as efflux pump and biofilm inhibitor to rejuvenate bactericidal effect of conventional antibiotics. Nano Resear.Lett. 12 (2017), 454
Rammo R.N.N. Evaluation of some antibiotics in combination activity againstisolates of Staphyococcus aureus and Pseudomonas aeruginosa. J. Al Nahrain Univer. Sci. 17(4) (2014), 174-179
Magihara M. , Crandon J.I. , Nicolau D.P. The efficacy and safty of antibiotic combination therapy for infections caused be G+ and G- organisms. Expert Opin. Drug Saf. 11(2) (2012), 221-233
Kankala R.K. , Lin N.Z. , Lee C.H. Combating antibiotic resistance through the synergistic effects of mesoporous silica –based hierarchical nanocomposites. Nanomater. 10 (2020), 597
Baker S. , Pasha A. , Satish S.H. Biogenic nanoparticles bearing antimicrobial activity and their synergistic effect with broad spectrum antibiotics: emerging strategy to combat drug resistant pathogens. Saudi Pharma. J. 25(1) (2017), 44-51
Gupta A. , Saleh N.M. , Das R. , Landis R.F. Synergistic antimicrobial therapy using nanoparticles and antibiotics for the treatment of multi-resistant bacterial infection. Nano Futures. 1(1) (2017), 015004
Zhang P. , Mao D. , Gao H. et al. Colonization of gut microbiota by plasmid carrying bacteria is facilitated by evolutionary adaptation to antibiotic treatment. ISME J. (2021)https://doi.org/10.1038/s41396-021-01771-x
Cold H.S. Vancomycin-resistant entercocci: mechanisms and clinical observations. Clin. Infect. Dis. 33(2) (2001), 210-219
Richards J.J. , Melander C. Small molecule approaches toward the non-microbial modulation of bacterial biofilm growth and maintenance. Antiinfect. Agents Med. Chem. 8(4) (2009), 295-314
Khameneh B. , Diab R. , Ghazvini K. , Bazzaz B.F. Breakthroughs in bacterialresistance mechanisms and the potential ways to control them. Microbial Pathogensis. 95 (2016), 32-42
Kon K. , M. Rai Antibiotic resistance mechanisms and new antimicrobial approaches. Academic Press, USA (2016)
Cheesman M.J. , Ilanko A. , Blonk B. , Cock I.E. Developing new antimicrobial therapies: are dynergistic combinations of plant extracts/compounds with conventional antibiotics the solution?Pharmacogn Rev, 11 (22) (2017), pp. 57-72
Eleraky N.K. , Allam A. , Hassan S.B. , Omer M.M. Nanomedecine fight against antibacterial resistance: an overview of recent pharmaceutical innovations. Pharmaceutics. 12(2) (2020), 42
Diab R. , Khameneh B. , Joubert O. , Duval R, Duval R. Insights in nanoparticle bacterium interactions: new frontiers to bypass bacterial resistance to antibiotics.Curr. Pharm. Des. 2(8) (2015), 4095-4105
Huh A.J., Kwon Y.J. “Nanoantibiotics”: a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era. J. Control Rel. 156 (2011), 128-145
Zhu X., A.F. Radovic-Moreno, Wu J., R. Langer, Shi J. Nano medicine in the management of microbial infection-overview and perspectives. NanoToday. (4) (2014), 478-498
World Health Organization (WHO) guidelines for drinking-water quality. http://www.who.int/water_sanitation_health/waterquality/guidelines/chemicals/zi-nc/en/.
Stankic S., Suman S., Haque F., Vidic J. Pure and multi metal oxide nanoparticles: synthesis, antibacterial and cytotoxic properties. J. Nanobiotechnology. 14 (1) (2016), 73
Wang L., Hu C., Shao L. The antimicrobial activity of nanoparticles:present situation and prospects for the future. Int. J.Nanomedicine. 12 (2017), 1227-1249
Vasanth S.B., Kuria G.A. Toxicity evaluation of silver nanoparticles synthesized by chemical and green route in different experimental models. Artif. Cells Nanomed. Biotechnol. 45 (8) (2017), 1721-1727
Rammo R.N.N. The role of MgO and CaO nano-particles on Staphylococcus epidermidis isolated from catheter indwelling patients.Indian J. Pub. Heal. Res. & Devlo. 10(8) (2019), 2182-2187
Rammo R.N.N. Resistance to biofilm formation by synergisticcombination of cerium oxide nanoparticles with antibiotics against wound/urinary catheter isolated bacteria. Pakistan J. Med. & Heal. Sci.15(4) (2021), 950-954
Nadeem M., Abbasi B.H. , Younas M. , Ahmad W. , Khan T. A review of the green synthesis and anti-microbial applications of gold nanoparticles.Green Chem. Lett. Rev. 10 (4) (2017), 216-227
Patra J.K., Baek K.H. Antibacterial activity and synergistic antibacterial potential of biosynthesized silver nanoparticles against food borne pathogenic bacteria along with its anticandidal and antioxidant effects. Front. Microbiol. 8 (2017), 167
Abdelghany T.M. , Aisha M.H. , Mohamed A.R. , Al Abboud A. , Alawlaqi M.M. , Magdah A.G. , et al. Recent advances in green synthesis of silver nanoparticles and their applications: about future directions. A review. Bionanoscience. 8 (3) (2018), 5-16
Abo-Shama U.H. , El-Gendy H. , Mousa W.S. Synergistic and antagonistic effects of metal nanoparticles in combination with antibiotics against resistance strains of pathogenic microorganisms. Infect. Drug Resist. 13(2020), 351-362
Barapatre A. , Aadil K.R. , Jha H. Synergistic antibacterial and antibiofilm activity of silver nanoparticles biosynthesized by lignin-degrading fungus. Bioresour. & Bioprocess 3 (2016), 8
Kotrange H. , Najda A. , Bains A. Gruszecki R. et al. Review: Metal and metal oxide nanoparticles as a novel antibiotic carrier for the direct delivery of antibiotics. Antibiotics Int. J. Mol. Sci. 22 (2021), 9596
Mohamad N.A.N. , Arham N.A. , Jai J. , Hadi A. Plant extract as reducing agent in synthesis of metallic nanoparticles: a review Adv. Mater. Res, 832 (2013), 350-355
Vijaya raghavan K., Ashok kumar T. Plant-mediated biosynthesis of metallic nanoparticles: a review of literature, factors affecting synthesis,characterization techniques and applications. J. Environ. Chem.Eng. 5 (5) (2017), 4866-4883
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
